• Publications
  • Influence
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
TLDR
The Commission recommends five priority investments to achieve a tuberculosis-free world within a generation, which answer the question of how countries with high-burden tuberculosis and their development partners should target their future investments. Expand
The COVID-19 Serology Studies Workshop: Recommendations and Challenges
TLDR
Recommendations for advancing serology assays as a tool to better understand SARS-CoV-2 infection and conducting crucial serology field studies to advance an understanding of immunity to SARS, including the correlation between serological test results and risk of reinfection are included. Expand
What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats
TLDR
This review highlights selected infectious disease outbreaks occurring during this period that are especially memorable and have helped to shape and refine the role of the NIAID's research and public health response to such threats. Expand
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
TLDR
This fourth edition of the guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV) is intended for clinicians and other health-care providers who care for HIV-infected persons. Expand
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable.
TLDR
The underlying science-based evidence supporting the Undetectable = Untransmittable (U = U) concept is examined and the behavioral, social, and legal implications associated with the acceptance are examined. Expand
The Pathway to a Universal Influenza Vaccine.
TLDR
A workshop was convened in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them and to identify candidates for a universal influenza vaccine. Expand
Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates
TLDR
This paper outlines points for consideration for developers, regulators, and other stakeholders working towards a licensed ZIKV vaccine, applicable to development of vaccines for other emerging infections where the size, unpredictability, and ephemeral nature of outbreaks makes clinical disease endpoint efficacy trials to demonstrate vaccine effectiveness infeasible. Expand
Comorbidities in Persons With HIV: The Lingering Challenge.
TLDR
To effectively solve the global health crisis HIV represents, the comorbidities among persons currently living with HIV must be addressed simultaneously with collective efforts to end the epidemic of new HIV transmissions. Expand
Reimagining the Research Approach to Tuberculosis†
TLDR
An accelerated biomedical research effort to address the many unanswered questions about the disease process itself and to develop improved and innovative countermeasures will facilitate the achievement of the aspirational goal of ending TB. Expand
PEPFAR - 15 Years and Counting the Lives Saved.
TLDR
PEPFAR — 15 Years and Counting the Lives Saved has had a major impact on the HIV/AIDS pandemic, allowing it to serve as a model for the control of other devastating infectious diseases. Expand
...
1
2
3
...